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Abstract 
Liver transplantation is the most effective treatment for treating liver cirrhosis. However, a limited number 
of donors, graft rejection, and other complications can undermine transplant success. It is considered that 
cell transplantation is an alternative approach of liver transplantation. We previously developed a protocol 
for hepatic differentiation of cluster of differentiation 117+ stem cells isolated from human exfoliated 
deciduous tooth pulp (SHEDs) under hydrogen sulfide exposure. These cells showed excellent hepatic 
function. Here, we investigated whether hepatocyte-like cell transplantation is effective for treating carbon 
tetrachloride (CCl4)-induced liver cirrhosis. SHEDs were hepatically differentiated, which was confirmed 
via immunological analyses and albumin concentration determination in the medium. Rats were 
intraperitoneally injected with CCl4 for and the differentiated cells were injected into rat spleen. 
Histopathological and immunohistochemical analyses were performed. Liver functions were serologically 
and pathologically determined. Quantitative real-time-polymerase chain reaction was implemented to 
clarify the treatment procedure of liver cirrhosis. In vitro-differentiated hepatocyte-like cells were positive 
for all examined hepatic markers. SHED-derived hepatocyte transplantation eliminated liver fibrosis and 
restored liver structure in rats. Liver immunohistochemical analyses showed the presence of human-specific 
hepatic markers, i.e., a large amount of human hepatic cells were very active in the liver and spleen. 
Serological tests revealed significant liver function recovery in the transplantation group. Expression of 
genes promoting fibrosis increased after cirrhosis induction but was suppressed after transplantation. Our 
 4 
results suggest that xenotransplantation of hepatocyte-like cells of human origin can treat cirrhosis. 
Moreover, cell-based therapy of chronic liver conditions may be an effective option. 
 
